Please login to the form below
WuXi AppTec
Established in December 2000, WuXi AppTec is a leading global pharmaceutical, biopharmaceutical, and medical device outsourcing company with operations in China and the United States. As a research-driven and customer-focused company, WuXi AppTec provides a broad and integrated portfolio of laboratory and manufacturing services from discovery to commercialization.
This is a FREE listing
Below are full profiles from other companies in this area
Oncosec
OncoSec is a clinical-stage biotechnology company focused on developing cytokine-based intratumoral immunotherapies to stimulate the body's immune system to target and attack cancer.
Syneos Health®
Syneos Health® (Nasdaq:SYNH) is the only fully integrated biopharmaceutical solutions organization. The Company, including a Contract Research Organization (CRO) and Contract Commercial Organization (CCO), is purpose-built to accelerate customer performance to address modern market realities. Learn more about how we are Shortening the distance from lab to life® at syneoshealth.com.
Company Details
WuXi AppTec
Telephone:+1 888- 794-0077
Address:
2540 Executive Drive
St. Paul
MN 55120
USA
Latest content from PMHub
- #DemandDiversity: For International Women's Day, we ask... why do women often suffer from more side effects than men?
- Women are largely prescribed exactly the same treatment regimens as men, with no account for the underlying differences in physiology and drug metabolism between the sexes.
COUCH Health
- Gene Editing and Precision Medicine: The Future of Healthcare?
- In the latest episode of Impetus Digital's Fireside Chat, Dr. Oscar Segurado, Chief Medical Officer at ASC Therapeutics, sits down with Natalie Yeadon to discuss advanced gene therapies, gene editing, personalized medicine, and much more. They also explore the many different hats he wears as CMO, consultant, and academic.
Impetus Digital
- CRM Design and Optimization for Life Science Organizations
- In the latest episode of Impetus Digital's Fireside Chat, I sit down with John Leombruno, CEO of OkRx, and discuss how his company is working to improve patient support program (PSP) strategy and operations in Canada. We also explore the impact of COVID-19 on PSPs, digital transformation, clinical trials, and much more!
Impetus Digital
- Live Webinar: Search Listening as a Tool to Inform Brand Strategy & Enable Patient-Centricity
- Fireside Chat with Julia Walsh, CEO of Brand Medicine International
Impetus Digital
